Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed…
Novo Nordisk A/S
Novo Nordisk stock climbs out of hole on FDA chief’s threat to block Hims and Hers pill
Novo Nordisk shares rallied on Friday in what’s still been a painful week as the Food…
Rising prices and weight-loss drugs are changing the way we eat — and food companies are racing to keep up
A shaky economy, wider adoption of weight-loss drugs, and changing tastes seem to conspire against some…
This biotech is halting its work with Novo Nordisk and laying off more people
Korro is the latest to rethink its ties with the Danish pharma company.
Novo Nordisk downgrades sales outlook again amid bidding war with Pfizer for Metsera
Management lowers full-year guidance, warns about competition, launches bid for Metsera.
Novo Nordisk CEO tells investors to expect weight-loss drug pricing to go down before it comes back up
Recently-appointed CEO Mike Doustdar has repeatedly reset expectations since his arrival. Pricing and regulatory pressure is…